Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.565
Peer-review started: October 27, 2020
First decision: November 20, 2020
Revised: November 29, 2020
Accepted: December 6, 2020
Article in press: December 6, 2020
Published online: January 26, 2021
Processing time: 85 Days and 3.2 Hours
Inositol has nine different isomers, of which the most representative of the human body are myoinositol (MI) and D-chiro-inositol (DCI).
The supplementation of inositol significantly improved insulin resistance in gestational diabetes mellitus (GDM) patients, and the effects of DCI on insulin resistance in GDM have not been reported.
Discuss the impact of different stereoisomers of inositol on insulin sensitivity of GDM patients.
Eighty GDM pregnant women were divided into four groups according to their specified treatment regimen.
There was no statistical difference in the baseline data of each group. The levels of 2 h blood glucose, glycosylated hemoglobin, fasting insulin, total cholesterol, and triglyceride in the B, C, and D groups were significantly lower than those in the control group (A group) after treatment (P < 0.05).
Treatment of different inositol stereoisomers (inositol MI and inositol DCI) can improve insulin sensitivity and reduce insulin resistance in diabetic patients. The inositol DCI was more effective in treating GDM than inositol MI.
The treatment of diabetes is diversified.
